Skip to content

Pharmacokinetic study by single intake of the test food (pilot study)

Pharmacokinetic study by single intake of the test food (pilot study) - Pharmacokinetic study by single intake of the test food (pilot study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050063
Enrollment
25
Registered
2023-01-21
Start date
2023-01-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Other
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Age: 20-34, healthy male 2) BMI: 18.5 kg/m2-24.9 kg/m2 3) Subjects who giving informed consent.

Exclusion criteria

Exclusion criteria: 1) Subjects with a serious medical history, or with a history of disorders of the digestive system, circulatory system (e.g., heart failure), endocrine system, etc. Subjects who have been judged to be inappropriate for the study by the principal investigator. 2) Subjects who have a history of gastrointestinal resection surgery, excluding appendectomy. 3) Subjects who are currently taking medication or being treated by a physician. 4) Subjects who must be scheduled to receive medical treatment or medication during the study period. 5) Subjects who plan to consume health foods or supplements other than the food under study after consent. 6) Subjects who are unable to consume the test food due to preference or allergy. Subjects who may have allergies related to the test food. 7) Heavy drinkers of alcohol and heavy smokers. 8) Subjects who have difficulty in taking blood samples. 9) Subjects who donated blood over 200mL in the past 4 weeks or over 400mL in the past 12 weeks. 10) Subjects who currently or will be participating in another clinical research study during the study period. 11) Subjects who have irregular sleep or eating habits due to night work or insomnia. 12) Subjects who are engaged in strenuous physical activity. 13) Subjects judged as unsuitable for the study by the responsible doctor for other reasons.

Design outcomes

Primary

MeasureTime frame
The time to maximum concentration (Tmax) of active ingredients

Secondary

MeasureTime frame
Blood concentration of active ingredients at each time point after ingestion of the test food Area Under the Curve(AUC) and Maximum serum concentration(Cmax) of active ingredients

Countries

Japan

Contacts

Public ContactReiko Naito

Kenkoin Medical Corporation Foundation Kenkoin Clinic

reiko-naito@kenkoin.jp03-3573-1153

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026